Ronne Yeo, PhD

Managing Director, EVX Ventures

Founding Vice President, Carmine Therapeutics

20181025_113906.jpg
  • LinkedIn - Black Circle

Dr. Ronne Yeo is a biotech investor, inventor and entrepreneur with a track record in leading R&D in a biotech company. Ronne joined Esco Ventures in 2016, the corporate investment arm of Esco Group and predecessor of EVX Ventures, and has since been identifying and evaluating investment opportunities in innovative drugs. Ronne played key roles towards developing EVX Ventures’ capabilities in biotech venture creation. Working alongside XQ and leveraging his scientific training in extracellular vesicles, he spearheaded company building efforts for Carmine Therapeutics, EVX Ventures’ flagship company and first to expand R&D operations into Boston MA. Carmine is pioneering non-viral gene therapy based on red blood cell extracellular vesicles, with Professors Harvey Lodish, Minh Le and Jiahai Shi as scientific co-founders. As Founding Vice President of Discovery, Ronne built and led the research team to create the REGENT™ Platform to enable targeted delivery of large, complex nucleic acid cargoes, leading to a research collaboration with Takeda Pharmaceuticals and Carmine being named a “Fierce 15” biotech company in 2020. Ronne currently oversees research in both the US and Singapore sites and is an inventor of key patents and know-hows that underlie Carmine’s gene therapy programs.

Ronne conceptualized and pioneered EVX Ventures’ initiatives to ensure a proprietary dealflow for investment or company creation. These are the Morphosis Fellowship program founded in 2018 and the PLATINUM grant launched in 2020. 

Prior to joining Esco Ventures, Ronne was Senior Research Fellow at A*STAR Institute of Medical Biology, where he was involved in the preclinical development of mesenchymal stem cell extracellular vesicles - a novel therapeutic modality targeting cardiovascular and immune disorders, currently being developed by A*STAR spin-off Paracrine Therapeutics. Ronne obtained his PhD from NUS Graduate School for Integrative Sciences and Engineering (NGS), and a BSc in Biological Sciences from Nanyang Technological University.